In vitro activity of cyclic dipeptides against gram-positive and gram-negative anaerobic bacteria and radioprotective effect on lung cells

Journal of Microbiology and Biotechnology

Volumn 16, Issue 1, 2006, Pages 158-162

  Rhee, Ki Hyeong ^a  

^a Kongju National University   (South Korea)

Author keywords

Anaerobic bacteria; Combined cyclic dipeptide; Radioprotective effect

Indexed keywords

CEFOXITIN; CLINDAMYCIN; CYCLO(LEUCYLPROLINE); CYCLO(PHENYLALANYLPROLINE); DIPEPTIDE; ERYTHROMYCIN; IMIPENEM; METRONIDAZOLE; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BIOLOGICAL ACTIVITY; CELL SURVIVAL; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG FIBROBLAST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; RADIATION PROTECTION; STREPTOMYCES; STRUCTURE ACTIVITY RELATION; SURVIVAL RATE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; STREPTOMYCES; STREPTOMYCES SP.;

EID: 32944459606     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Carl, E. N., L. Ann, and P. Ingela. 1988. Susceptibility of anaerobic bacteria to ALP 201. Antimicrob. Agents Chemother. 33: 2137-2139.
2. Finegold, S. 1995. Anaerobic infections in humans: An overview. Anaerobe 1: 3-9.
3. Graz, C. J. M. and H. M. Cowley. 1997. Energy state in HT-29 cells is linked to differentiation. In Vitro Cell Dev. Biol. 33: 277-281.
4. Graz, C. J. M., G. D. Grant, S. C. Brauns, A. Hunt, H. Jamie, and P. J. Milne. 2000. Cyclic dipeptides in the induction of maturation for cancer therapy. J. Pharm. Pharmacol. 52: 75-82.
5. Hedberg, M. and C. E. Nord. 1996. Antimicrobial-resistant anaerobic bacteria in human infections. Med. Microbiol. Lett. 5: 295-394.
6. Holdeman, L. V., E. P. Cato, and W. E. Moore. 1977. Anaerobic Laboratory Manual, 4th Ed. Virginia Polytechnic Institute and State University, Blacksburg.
7. Kim, Y. J., K. W. Lee, D. O. Kim, T. W. Kim, S. K. Lee, and H. J. Lee. 2004. In vivo antitumor activity of hydrophilic arginine-conjugated linoleic acid complex. J. Microbiol. Biotechnol. 14: 411-414.
8. King, T. C., D. Schlessinger, and D. J. Krogstad. 1981. The assessment of antimicrobial combinations. Rev. Infect. Dis. 3: 627-633.
9. Lee, H. J., K. W. Lee, K. H. Kim, H. K. Kim, and H. J. Lee. 2004. Antitumor activity of peptide fraction from traditional Korean soy sauce. J. Microbiol. Biotechnol. 14: 628-630.
10. Mian, X., H. S. Floyd, S. M. Greth, W. C. L. Chang, K. Lohman, R. Stoyanova, G. L. Kucera, T. E. Kute, M. C. Willingham, and M. S. Miller. 2004. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: Potential mechanisms for its chemotherapeutic effects. Toxicol. Appl. Pharmacol. 195: 232-246.
11. Rhee, K. H. 2004. Cyclic dipeptides exhibit synergistic, broad spectrum antimicrobial effects and have anti-mutagenic properties. Int. J. Antimicrob. Agents 24: 423-427.
12. Rhee, K. H. 2002. Isolation and characterization of Streptomyces sp. KH-614 producing anti-VRE (vancomycin-resistant enterococci) antibiotics. J. Gen. Appl. Microbiol. 48: 321-327.
13. Rhee, K. H. 2002. Inhibition of DNA topoisomerase I by cyclo(L-prolyl-L-phenylalanyl) isolated from Streptomyces sp. AMLK-335. J. Microbiol. Biotechnol. 12: 1013-1016.
14. Rhee, K. H., K. H. Choi, C. J. Kim, and C. H. Kim. 2001. Identification of Streptomyces sp. AMLK-335 producing antibiotic substance inhibitory to VRE (vancomycin-resistant enterococci). J. Microbiol. Biotechnol. 11: 469-474.
15. Richard, A. V., M. Y. Diane, M. R. Ellen, and M. E. Roger. 1990. Comparative in vitro activities of a new quinolone, win 57273, and piperacillin plus tazobactam against anaerobic bacteria. Antimicrob. Agents Chemother. 34: 1858-1861.
16. Shutter, V. L., D. M. Citron, and S. M. Finegold. 1980. Wadsworth Anaerobic Bacteriology Manual, 3rd Ed. The C. V. Mosby Co., St. Louis, MO, U.S.A.
17. Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd. 1990. New colometric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82: 1107-1112.